During this session, we will review the PassItOn study from Vanderbilt University and a prophylaxis clinical trial from Johns Hopkins to better understand the methodology, design, and status of these trials. The session will also feature discussions of how best to optimize collection of COVID-19 convalescent plasma in terms of (1) workflow and (2) maximizing the safe collection of high antibody titer units.
Employ changes and optimize to their donor management workflow
Establish criteria for frequent plasma collections that recognizes the need to preserve donor safety
Determine whether their hospital, staff, or patients can be enrolled in one of the ongoing RCTs for CCP
Associate Professor; Associate Director, Transfusion Medicine,
Johns Hopkins University School of Medicine
Chief Medical Officer, Associate Professor of Laboratory Medicine and Pathology, Director, Blood Bank Laboratory, Associate Director, Clinical Laboratories,
University of Minnesota